A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.
Communicating Science to Business: a three part mini-course
22 October 2013
These workshops are designed to help to prepare academics looking to maximise the benefits of presenting their academic research to business audiences.
Attend all of the sessions to maximise the value of participating. Participants who attend three workshops in the same academic year will receive a CPD (Continued Personal Development) certificate to mark their achievements.